The University of the Sciences welcomed its first startup last month.
Enzium, a biotech company previously located in Pittsburgh, will be headquartered at the college for at least one year, according to a release. It will be the first time that an outside startup opens an office at the school, the release said.
Enzium came to University of the Sciences in part because Enzium cofounder Peter Berget is now the chair of the biology department at the college. Berget, who joined University of the Sciences in August of 2011, developed the technology behind Enzium while he was a professor at Carnegie Mellon.
Led by Crystal Falco, Enzium manufactures kits that detect enzyme activity. The company is backed by life sciences investor BioAdvance.
University City biotech firm Cabaletta Bio Inc. goes public in $74.8M IPO
Success in life sciences begets more success: What Philly leaders say about the industry’s growth
Philadelphia is having its best year for VC deals since 2000
How ShopRunner’s mentorship program is pushing its employees to think beyond their fields
Exton cell and gene therapy company Fibrocell will be acquired for $63.3M
Carisma Therapeutics raised nearly $60M in Series A funding. Now what?
A Center City biotech company is using an algorithm to help patients with memory loss
How Relay is helping enterprise clients get proactive about customer engagement
Sign-up for daily news updates from Technical.ly Philadelphia